JAMA Oncology


Publication Venue For

  • Safety and Efficacy of Durvalumab with or Without Tremelimumab in Patients with PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.  5:195-203. 2019
  • Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.  4. 2018
  • Tucatinib combined with ado-Trastuzumab emtansine in advanced ERBB2/HER2-positive metastatic breast cancer: A Phase 1b Clinical Trial.  4:1214-1220. 2018
  • Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A clinical trial.  4:977-984. 2018
  • Possible underestimation of the provision of palliative care.  4:884-885. 2018
  • A magnetic resonance imaging–based prediction model for prostate biopsy risk stratification.  4:678-685. 2018
  • Association of mismatch repair mutation with age at cancer onset in lynch syndrome implications for stratified surveillance strategies.  3:E1-E5. 2017
  • Hospital-based end-of-life care and costs for older patients with malignant brain tumors.  3:1581-1582. 2017
  • Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era a correlative analysis based on nrg oncology RTOG 0525.  3:784-792. 2017
  • Resource use and medicare costs during lay navigation for geriatric patients with cancer.  3:817-825. 2017
  • Drawing the Line in Risk-Reducing Gynecologic Surgery in Women with a BRCA Mutation.  2:1409-1411. 2016
  • Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.  2:1277-1286. 2016
  • Inherited mutations in women with ovarian carcinoma.  2:482-490. 2016
  • Somatic mosaic mutations in PPM1D and TP53 in the blood of women with ovarian carcinoma.  2:370-372. 2016
  • The Global Burden of Cancer 2013.  1:505-527. 2015
  • Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: A children's oncology group study.  1:287-295. 2015
  • International Standard Serial Number (issn)

  • 2374-2437
  • Electronic International Standard Serial Number (eissn)

  • 2374-2445